Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function

Journal of Clinical Investigation

Volumn 115, Issue 10, 2005, Pages 2673-2678

  Wright, Casey W ^a   Duckett, Colin S ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Med Sci I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; FAS ASSOCIATED DEATH DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; BACULOVIRUS; CANCER CELL; CARCINOGENESIS; CELL DEATH; DNA DAMAGE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; MELANOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NEOPLASM; NONHUMAN; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM PROTEINS; NEOPLASMS;

EID: 26444470888     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI26251     Document Type: Review

References (86)

1. Crook, N.E., Clem, R.J., and Miller, L.K. 1993. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif J. Virol. 67:2168-2174.
2. Birnbaum, M.J., Clem, R.J., and Miller, L.K. 1994. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs J. Virol 68:2521-2528.
3. Clem, R.J., Fechheimer, M., and Miller, L.K. 1991. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science. 254:1388-1390.
4. Salvesen, G.S., and Duckett, C.S. 2002. IAP proteins: blocking the road to death's door [review]. Nat. Rev. Mol. Cell Biol. 3:401-410.
5. Uren, A.G., Coulson, E.J., and Vaux, D.L. 1998. Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. Trends Biochem. Sci. 23:159-162.
6. Huang, H.-K., et al. 2000. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J. Biol. Chem. 275:26661-26664.
7. Olson, M.R., et al. 2003. A GH3-like domain in reaper is required for mitochondrial localization and induction of IAP degradation. J. Biol. Chem. 278:44758-44768.
8. Suzuki, Y., Nakabayashi, Y., and Takahashi, R. 2001. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. U. S. A. 98:8662-8667.
9. Yang, Y., Fang, S., Jensen, J.P., Weissman, A.M., and Ashwell, J.D. 2000. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 288:874-877.
10. Jesenberger, V., and Jentsch, S. 2002. Deadly encounter: ubiquitin meets apoptosis. Nat. Rev. Mol. Cell Biol. 3:112-121.
11. Ambrosini, G., Adida, C., and Altieri, D.C. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:917-921.
12. Uren, A.G., et al. 2000. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr. Biol. 10:1319-1328.
13. Okada, H., et al. 2004. Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J. Exp. Med. 199:399-410.
14. Uren, A.G., et al. 1999. Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. Proc. Natl. Acad. Sci. U. S. A. 96:10170-10175.
15. Fraser, A.G., James, C., Evan, G.I., and Hengartner, M.O. 1999. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr. Biol. 9:292-301.
16. Alfieri, D.C. 2003. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogens. 22:8581-8589.
17. Holcik, M., Gibson, H., and Korneluk, R.G. 2001. XIAP: apoptotic brake and promising therapeutic target. Apoptosis. 6:253-261.
18. Li, X., Yang, Y., and Ashwell, J.D. 2002. TNF-RII and C-IAP1 mediate ubiquitination and degradation of TRAF2. Nature. 416:345-347.
19. Altieri, D.C. 2004. Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. J. Cell. Biochem. 92:656-663.
20. Deveraux, Q.L., Takahashi, R., Salvesen, G.S., and Reed, J.C. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:300-304.
21. Shi, Y. 2004. Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci. 13:1979-1987.
22. Lavrik, I.N., Golks, A., and Krammer, P.H. 2005. Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 115:2665-2672. doi:10.1172/JCI26252.
23. Shiozaki, E.N., and Shi, Y. 2004. Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology. Trends Biochem. Sci. 29:486-494.
24. Roy, N., Deveraux, Q.L., Takahashi, R., Salvesen, G.S., and Reed, J.C. 1997. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific Caspases. EMBO J. 16:6914-6925.
25. Schimmer, A.D. 2004. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 64:7183-7190.
26. Sasaki, H., Sheng, Y., Kotsuji, F., and Tsang, B.K. 2000. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res. 60:5659-5666.
27. Yang, L., Cao, Z., Yan, H., and Wood, W.C. 2003. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 63:6815-6824.
28. Bilim, V., Kasahara, T., Hara, N., Takahashi, K., and Tomita, Y. 2003. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int. J. Cancer. 103:29-37.
29. McManus, D.C., et al. 2004. Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene. 23:8105-8117.
30. Hofer-Warbinek, R., et al. 2000. Activation of NF-κB by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem. 275:22064-22068.
31. Birkey Reffey, S., Wurthner, J.U., Parks, W.T., Roberts, A.B., and Duckett, C.S. 2001. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-β signaling. J. Biol. Chem. 276:26542-26549.
32. Chu, Z.-L., et al. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis C-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. U.S.A. 94:10057-10062.
33. Gordon, G.J., et al. 2002. Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis. 23:1017-1024.
34. Vucic, D., Stennicke, H.R., Pisabarro, M.T., Salvesen, G.S., and Dixit, V.M. 2000. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr. Biol. 10:1359-1366.
35. Dierlamm, J., et al. 1999. The apoptosis inhibitor gene AP12 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood. 93:3601-3609.
36. Uren, A.G., et al. 2000. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell. 6:961-967.
37. Tamm, I., et al. 2000. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res. 6:1796-1803.
38. Ferreira, C.G., et al. 2001. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients. Clin. Cancer Res. 7:2468-2474.
39. Carter, B.Z., et al. 2003. Caspase-independent cell death in AML: caspase inhibition in vitro with pancaspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis. Blood. 102:4179-4186.
40. Imoto, I., et al. 2001. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res. 61:6629-6634.
41. Budihardjo, I., Oliver, H., Lutter, M., Luo, X., and Wang, X. 1999. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15:269-290.
42. Hsu, H., Shu, H.-B., Pan, M.-G., and Goeddel, D.V. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:299-308.
43. Kischkel, F.C., et al. 199S. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:5579-5588.
44. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced death. Cell. 85:803-815.
45. Desagher, S., and Martinou, J.C. 2000. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:369-377.
46. Li, P., et al. 1997. Cytochrome cand dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:479-489.
47. Zou, H., Henzel, W.J., Liu, X., Lutschg, A., and Wang, X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:405-413.
48. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490.
49. Li, H., Zhu, H., Xu, C.J., and Yuan, J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:491-501.
50. Salvesen, G.S., and Abrams, J.M. 2004. Caspase activation: stepping on the gas or releasing the brakes? Lessons from humans and flies [review]. Oncogene. 23:2774-2784.
51. Bratton, S.B., Lewis, J., Butterworth, M., Duckett, C.S., and Cohen, G.M. 2002. XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis. Cell Death Differ. 9:881-892.
52. Stennicke, H.R., Ryan, C.A., and Salvesen, G.S. 2002. Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem. Sci. 27:94-101.
53. Verhagen, A.M., et al.2000.Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 102:43-53.
54. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:33-42.
55. Wu, J.W., Cocina, A.E., Chai, J., Hay, B.A., and Shi, Y. 2001. Structural analysis of a functional DIAP1 fragment bound to grim and hid peptides. Mol. Cell. 8:95-104.
56. Wright, C.W., and Clem, R.J. 2001. Sequence requirements for hid binding and apoptosis regulation in the anti-apoptotic baculovirus protein Op-IAP: hid binds Op-IAP in a manner similar to Smac binding of XIAP. J. Biol. Chem. 277:2454-2462.
57. Shi, Y. 2002. A conserved tetrapeptide motif: potentiating apoptosis through IAP-binding. Cell Death Differ. 9:93-95.
58. Hegde, R., et al. 2001. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts IAP-caspase interaction. J. Biol. Chem. 277:432-438.
59. Martins, L.M., et al. 2001. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a Reaper-like motif. J. Biol. Chem. 277:439-444.
60. Suzuki, Y., et al. 2001. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell. 8:613-621.
61. van Loo, G., et al. 2002. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ. 9:20-26.
62. Vaux, D.L., and Silke, J. 2003. Mammalian mitochondrial IAP binding proteins. Biochem. Biophys. Res. Commun. 304:499-504.
63. Hegde, R., et al. 2003. The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein. J. Biol. Chem. 278:38699-38706.
64. Martins, L.M., et al. 2004. Neuroprotective role of the reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell. Biol. 24:9848-9862.
65. Huang, Y., Lu, M., and Wu, H. 2004. Antagonizing XIAP-mediated caspase-3 inhibition. Achilles' heel of cancers? [review]. Cancer Cell. 5:1-2.
66. Fulda, S., Wick, W., Weller, M., and Debatin, K.M. 2002. Smac agonists sensitize for Apo2L/TRAIL-or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat. Med. 8:808-815.
67. Arnt, C.R., Chiorean, M.V., Heldebrant, M.P., Gores, G.J., and Kaufmann, S.H. 2002. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J Biol. Chem. 277:44236-44243.
68. Li, C.J., Friedman, D.J., Wang, C., Metelev, V., and Pardee, A.B. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science. 268:429-431.
69. Sun, H., et al. 2004. Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site. J. Med. Chem. 47:4147-4150.
70. Oost, T.K., et al. 2004. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J. Med. Chem. 47:4417-4426.
71. Li, L., et al. 2004. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science. 305:1471-1474.
72. Wu, T.Y., Wagner, K.W., Bursulaya, B., Schultz, P.G., and Deveraux, Q.L. 2003. Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction. Chem. Biol. 10:759-767.
73. Schimmer, A.D., et al. 2004. Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad and tumor activity. Cancer Cell. 5:25-35.
74. Cao, C., Mu, Y., Hallahan, D.E., and Lu, B. 2004. XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogens. 23:7047-7052.
75. Harlin, H., Reffey, S.B., Duckett, C.S., Lindsten, T., and Thompson, C.B. 2001. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21:3604-3608.
76. Potts, P.R., Singh, S., Knezek, M., Thompson, C.B., and Deshmukh, M. 2003. Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J. Cell Biol. 163:789-799.
77. Burstein, E., et al. 2004. A novel role for XIAP in copper homeostasis through regulation of MURR1. EMBO J. 23:244-254.
78. Olayioye, M.A., et al. 2005. XIAP-deficiency leads to delayed lobuloalveolar development in the mammary gland. Cell Death Differ. 12:87-90.
79. Sanna, M.G., Duckett, C.S., Richter, B.W.M., Thompson, C.B., and Ulevitch, R.J. 1998. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc. Natl. Acad. Sci. U. S. A. 95:6015-6020.
80. Asselin, E., Mills, G.B., and Tsang, B.K. 2001. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res. 61:1862-1868.
81. van De Sluis, B., Rothuizen, J., Pearson, P.L., van Oost, B.A., and Wijmenga, C. 2002. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum. Mol. Genet. 11:165-173.
82. Shiozaki, E.N., et al. 2003. Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell. 11:519-527.
83. Liu, Z., et al. 2000. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature. 408:1004-1008.
84. Wu, G., et al. 2000. Structural basis of IAP recognition by Smac/DIABLO. Nature. 408:1008-1012.
85. Martz, E. 2002, Protein explorer: easy yet powerful macromolecular visualization. Trends Biochem. Sci. 27:107-109.
86. Protein Explorer, http://proteinexplorer.org.